Koen van Besien

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Phenomena

Recurrence

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Fenske Timothy S; Hari Parameswaran N; Carreras Jeanette; Zhang Mei-Jie; Kamble Rammurti T; Bolwell Brian J; Cairo Mitchell S; Champlin Richard E; Chen Yi-Bin; Freytes César O; Gale Robert Peter; Hale Gregory A; Ilhan Osman; Khoury H Jean; Lister John; Maharaj Dipnarine; Marks David I; Munker Reinhold; Pecora Andrew L; Rowlings Philip A; Shea Thomas C; Stiff Patrick; Wiernik Peter H; Winter Jane N; Rizzo J Douglas; van Besien Koen; Lazarus Hillard M; Vose Julie M
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Richa Elie; Papari Mona; Allen JoAnn; Martinez Guadalupe; Wickrema Amittha; Anastasi John; Van Besien Koen; Artz Andrew
Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization.
van Besien Koen; Dew Alexander; Lin Shang; Joseph Loren; Godley Lucy A; Larson Richard A; Odenike Toyosi; Rich Elizabeth; Stock Wendy; Wickrema Amittha; Artz Andrew S
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Koen van Besien (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Fenske Timothy S; Hari Parameswaran N; Carreras Jeanette; Zhang Mei-Jie; Kamble Rammurti T; Bolwell Brian J; Cairo Mitchell S; Champlin Richard E; Chen Yi-Bin; Freytes César O; Gale Robert Peter; Hale Gregory A; Ilhan Osman; Khoury H Jean; Lister John; Maharaj Dipnarine; Marks David I; Munker Reinhold; Pecora Andrew L; Rowlings Philip A; Shea Thomas C; Stiff Patrick; Wiernik Peter H; Winter Jane N; Rizzo J Douglas; van Besien Koen; Lazarus Hillard M; Vose Julie M
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1455-64.
2009: Richa Elie; Papari Mona; Allen JoAnn; Martinez Guadalupe; Wickrema Amittha; Anastasi John; Van Besien Koen; Artz Andrew
Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1394-9.
2009: van Besien Koen; Dew Alexander; Lin Shang; Joseph Loren; Godley Lucy A; Larson Richard A; Odenike Toyosi; Rich Elizabeth; Stock Wendy; Wickrema Amittha; Artz Andrew S
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
Leukemia & lymphoma 2009;50(11):1809-17.
2009: Sharma Manish; Moore Jocelyn; Nguyen Vu; Van Besien Koen
Fatal CMV pneumonitis in a lymphoma patient treated with rituximab.
American journal of hematology 2009;84(9):614-6.
2009: O'Donnell Peter H; Swanson Kate; Josephson Michelle A; Artz Andrew S; Parsad Sandeep D; Ramaprasad Charulata; Pursell Kenneth; Rich Elizabeth; Stock Wendy; van Besien Koen
BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1038-1048.e1.
2009: Loberiza Fausto R; Lee Stephanie J; Freytes Cesar O; Giralt Sergio A; Van Besien Koen; Kurian Seira; del Cerro Paula; Toro Juan J; Williams Loretta A; Ketelsen Seth W; Navarro Willis H; Rizzo J Douglas
Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(8):903-9.
2009: van Besien Koen; Carreras Jeanette; Bierman Philip J; Logan Brent R; Molina Arturo; King Roberta; Nelson Gene; Fay Joseph W; Champlin Richard E; Lazarus Hillard M; Vose Julie M; Hari Parameswaran N
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(5):554-63.
2009: Martin Paul J; Storer Barry E; Rowley Scott D; Flowers Mary E D; Lee Stephanie J; Carpenter Paul A; Wingard John R; Shaughnessy Paul J; DeVetten Marcel P; Jagasia Madan; Fay Joseph W; van Besien Koen; Gupta Vikas; Kitko Carrie; Johnston Laura J; Maziarz Richard T; Arora Mukta; Jacobson Pamala A; Weisdorf Daniel
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.
Blood 2009;113(21):5074-82.
2009: Poiré Xavier; Artz Andrew; Larson Richard A; Kline Justin; Odenike Olatoyosi; Rich Elizabeth; Godley Lucy; Stock Wendy; van Besien Koen
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
Leukemia & lymphoma 2009;50(1):85-91.
2009: Devetten Marcel P; Hari Parameswaran N; Carreras Jeanette; Logan Brent R; van Besien Koen; Bredeson Christopher N; Freytes César O; Gale Robert Peter; Gibson John; Giralt Sergio A; Goldstein Steven C; Gupta Vikas; Marks David I; Maziarz Richard T; Vose Julie M; Lazarus Hillard M; Anderlini Paolo
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1):109-17.
2009: Foss Francine; van Besien Koen
Reduced-intensity and nonmyeloablative conditioning regimens.
Cancer treatment and research 2009;144():1-24.
2008: Lazarus Hillard M; Carreras Jeanette; Boudreau Christian; Loberiza Fausto R; Armitage James O; Bolwell Brian J; Freytes César O; Gale Robert Peter; Gibson John; Hale Gregory A; Inwards David J; LeMaistre Charles F; Maharaj Dipnarine; Marks David I; Miller Alan M; Pavlovsky Santiago; Schouten Harry C; van Besien Koen; Vose Julie M; Bitran Jacob D; Khouri Issa F; McCarthy Philip L; Yu Hongmei; Rowlings Philip; Serna Derek S; Horowitz Mary M; Rizzo J Douglas;
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1323-33.
2008: Artz Andrew S; Wickrema Amittha; Dinner Shira; Godley Lucy A; Kocherginsky Masha; Odenike Olatoyosi; Rich Elizabeth S; Stock Wendy; Ulaszek Jodie; Larson Richard A; van Besien Koen
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1209-16.
2008: Calderwood Michael S; Mauer Andreas; Tolentino Jocelyn; Flores Ernesto; van Besien Koen; Pursell Ken; Weber Stephen G
Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2008;29(11):1019-25.
2008: Flowers Mary E D; Apperley Jane F; van Besien Koen; Elmaagacli Ahmet; Grigg Andrew; Reddy Vijay; Bacigalupo Andrea; Kolb Hans-Jochem; Bouzas Luis; Michallet Mauricette; Prince H Miles; Knobler Robert; Parenti Dennis; Gallo Jose; Greinix Hildegard T
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.
Blood 2008;112(7):2667-74.
2008: Nguyen Vu; van Besien Koen
Late relapse following allogeneic transplant for chronic lymphocytic leukemia: how good are graft versus leukemia effects?
Leukemia & lymphoma 2008;49(9):1651-2.
2008: van Besien Koen; Hari Parameswaran
Nonmyeloablative conditioning for relapsed follicular lymphoma.
Blood 2008;112(6):2585-6; author reply 2586-7.
2008: Dew Alexander; Collins Demetria; Artz Andrew; Rich Elizabeth; Stock Wendy; Swanson Kate; van Besien Koen
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):938-41.
2008: Smith Sonali M; van Besien Koen; Carreras Jeanette; Bashey Asad; Cairo Mitchell S; Freytes Cesar O; Gale Robert Peter; Hale Gregory A; Hayes-Lattin Brandon; Holmberg Leona A; Keating Armand; Maziarz Richard T; McCarthy Philip L; Navarro Willis H; Pavlovsky Santiago; Schouten Harry C; Seftel Matthew; Wiernik Peter H; Vose Julie M; Lazarus Hillard M; Hari Parameswaran
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):904-12.
2008: Rosenbaum Cara; Peace David; Rich Elizabeth; Van Besien Koen
Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):719-23.
2008: Gordon Melinda K; Sher Dorie; Karrison Theodore; Kebriaei Partow; Chuang Karen; Zhang Yanming; McDonnell Diane; Artz Andrew; Godley Lucy; Odenike Olatoyosi; Rich Elizabeth; Michaelis Laura; Thirman Michael J; Wickrema Amittha; van Besien Koen; Larson Richard A; Stock Wendy
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
Leukemia & lymphoma 2008;49(3):531-7.
2008: Kang Jeong-Ah; Zhou Ying; Weis Tahlia L; Liu Hui; Ulaszek Jodie; Satgurunathan Nilesh; Zhou Li; van Besien Koen; Crispino John; Verma Amit; Low Philip S; Wickrema Amittha
Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts.
The Journal of biological chemistry 2008;283(11):6997-7006.
2008: Kline J; Subbiah S; Lazarus H M; van Besien K
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Bone marrow transplantation 2008;41(6):505-13.
2008: Hari Parameswaran; Carreras Jeanette; Zhang Mei-Jie; Gale Robert Peter; Bolwell Brian J; Bredeson Christopher N; Burns Linda J; Cairo Mitchell S; Freytes César O; Goldstein Steven C; Hale Gregory A; Inwards David J; Lemaistre Charles F; Maharaj Dipnarine; Marks David I; Schouten Harry C; Slavin Shimon; Vose Julie M; Lazarus Hillard M; van Besien Koen
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):236-45.
2008: van Besien Koen; Gisselbrecht Christian; Pfreundschuh Michael; Zucca Emanuele
Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.
Leukemia & lymphoma 2008;49 Suppl 1():52-8.
2007: Pollyea D A; Artz A S; Stock W; Daugherty C; Godley L; Odenike O M; Rich E; Smith S M; Zimmerman T; Zhang Y; Huo D; Larson R; van Besien K
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2007;40(11):1027-32.
2007: Hill Brian T; Kondapalli Lavayna; Artz Andrew; Smith Sonali; Rich Elizabeth; Godley Lucy; Odenike Olatoyosi; Pursell Kenneth J; Larson Richard A; Stock Wendy; van Besien Koen
Successful allogeneic transplantation of patients with suspected prior invasive mold infection.
Leukemia & lymphoma 2007;48(9):1799-805.
2007: Michaelis L; Lin S; Joseph L; Artz A S; Kline J; Pollyea D; Stock W; Rich E; Collins-Jones D; Casey B; Del Cerro P; van Besien K
Chimerism does not predict for outcome after alemtuzumab based conditioning.
Bone marrow transplantation 2007;40(2):181.
2007: Samara Michael A; Brennan J Matthew; Van Besien Koen; Larson Richard A
Cardiac tamponade in a patient with chronic lymphocytic leukemia.
Leukemia & lymphoma 2007;48(4):829-32.
2007: Gordon Melinda K; Kraus Madeleine; van Besien Koen
Interdigitating dendritic cell tumors in two patients exposed to topical calcineurin inhibitors.
Leukemia & lymphoma 2007;48(4):816-8.
2007: van Besien Koen; Schouten Harry
Follicular lymphoma: a historical overview.
Leukemia & lymphoma 2007;48(2):232-43.
2007: Margolin Kim A; van Besien Koen; Peace David J
An introduction to foundation and industry-sponsored research: practical and ethical considerations.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2007;():498-503.
2006: Artz Andrew S; Pollyea Daniel A; Kocherginsky Masha; Stock Wendy; Rich Elizabeth; Odenike Olatoyosi; Zimmerman Todd; Smith Sonali; Godley Lucy; Thirman Michael; Daugherty Christopher; Extermann Martine; Larson Richard; van Besien Koen
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(9):954-64.
2006: Kline J; van Besien K; Nathanson J; Noffsinger A; Artz A
Severe intestinal graft-versus-host disease following autologous stem cell transplantation.
Bone marrow transplantation 2006;38(5):391-2.
2006: Van Besien Koen
The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma.
Blood reviews 2006;20(5):235-44.
2006: van Besien Koen
Toxicity of high dose BCNU: how much is too much?
Leukemia & lymphoma 2006;47(8):1447-8.
2006: van Besien Koen
Standardizing chronic graft-versus-host disease.
Future oncology (London, England) 2006;2(4):459-62.
2006: Danaher Eileen Hacker; Ferrans Carol; Verlen Ellen; Ravandi Farhad; van Besien Koen; Gelms Julie; Dieterle Natalie
Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.
Oncology nursing forum 2006;33(3):614-24.
2006: Villano J Lee; Collins Cindy A; Manasanch Elisabet E; Ramaprasad Charulata; van Besien Koen
Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.
The lancet oncology 2006;7(5):436-8.
2006: Navarro Willis H; Loberiza Fausto R; Bajorunaite Ruta; van Besien Koen; Vose Julie M; Lazarus Hillard M; Rizzo J Douglas
Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):541-51.
2006: Artz Andrew S; Kocherginsky Masha; Van Besien Koen
Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantation.
British journal of haematology 2006;132(6):747-54.
2006: Kline J; Pollyea D A; Stock W; Artz A; Rich E; Godley L; Zimmerman T; Thompson K; Pursell K; Larson R A; van Besien K
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
Bone marrow transplantation 2006;37(3):307-10.
2005: Schwake Christopher J; Eapen Mary; Lee Stephanie J; Freytes César O; Giralt Sergio A; Navarro Willis H; Rizzo J Douglas; van Besien Koen; Loberiza Fausto R
Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(12):988-98.
2005: van Besien Koen; Deeg H Joachim
Hematopoietic stem cell transplantation for myelofibrosis.
Seminars in oncology 2005;32(4):414-21.
2005: van Besien Koen; Artz A; Smith S; Cao D; Rich S; Godley L; Jones D; Del Cerro P; Bennett D; Casey B; Odenike O; Thirman M; Daugherty C; Wickrema A; Zimmerman T; Larson R A; Stock W
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5728-38.
2005: van Besien Koen; Smith Sonali; Lazarus Hillard M
Therapeutic options for patients with Hodgkin's disease and non-Hodgkin's lymphoma who relapse after autologous transplant.
Current treatment options in oncology 2005;6(4):279-87.
2005: Kebriaei P; Kline J; Stock W; Kasza K; Le Beau M M; Larson R A; van Besien K
Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
Bone marrow transplantation 2005;35(10):965-70.
2005: Van Besien Koen
Autologous and allogeneic stem cell transplantation in follicular lymphoma.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2005;32(1):45-53.
2005: Roszkowski Jeffrey J; Lyons Gretchen E; Kast W Martin; Yee Cassian; Van Besien Koen; Nishimura Michael I
Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
Cancer research 2005;65(4):1570-6.
2005: Scarpace Sarah L; Hahn Theresa; Roy Hilary; Brown Karen; Paplham Pamela; Chanan-Khan Asher; van Besien Koen; McCarthy Philip L
Arterial thrombosis in four patients treated with thalidomide.
Leukemia & lymphoma 2005;46(2):239-42.
2005: Artz A S; Van Besien K; Zimmerman T; Gajewski T F; Rini B I; Hu H S; Stadler W M; Vogelzang N J
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience.
Bone marrow transplantation 2005;35(3):253-60.
2005: van Besien K; Artz A; Stock W
Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(1):31-3.
2004: Tse W W; Lazarus H M; Van Besien K
Stem cell transplantation in follicular lymphoma: progress at last?
Bone marrow transplantation 2004;34(11):929-38.
2004: Freytes César O; Loberiza Fausto R; Rizzo J Douglas; Bashey Asad; Bredeson Christopher N; Cairo Mitchell S; Gale Robert Peter; Horowitz Mary M; Klumpp Thomas R; Martino Rodrigo; McCarthy Philip L; Molina Arturo; Pavlovsky Santiago; Pecora Andrew L; Serna Derek S; Tsai Tsuong; Zhang Mei-Jie; Vose Julie M; Lazarus Hillard M; van Besien Koen;
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.
Blood 2004;104(12):3797-803.
2004: Van Besien Koen; Smith Sonali; Anastasi John; Larson Richard; Thirman Michael; Odenike Toyosi; Stock Wendy
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection.
Blood 2004;103(11):4373-4.
2004: Van Besien Koen; Mehra Rakesh; Wadehra Navin; Stock Wendy; Khouri Issa; Giralt Sergio; Devine Steve; Wickrema Amittha; Peace David; Sosman Jeff; Gajewski Jim; Champlin Richard
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(6):386-94.
2004: Popat U; Hosing C; Saliba R M; Anderlini P; van Besien K; Przepiorka D; Khouri I F; Gajewski J; Claxton D; Giralt S; Rodriguez M; Romaguera J; Hagemeister F; Ha C; Cox J; Cabanillas F; Andersson B S; Champlin R E
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Bone marrow transplantation 2004;33(10):1015-23.
2004: Winter Jane N; Gascoyne Randy D; Van Besien Koen
Low-grade lymphoma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004;():203-20.
2003: van Besien Koen; Loberiza Fausto R; Bajorunaite Ruta; Armitage James O; Bashey Asad; Burns Linda J; Freytes Cesar O; Gibson John; Horowitz Mary M; Inwards David J; Marks David I; Martino Rodrigo; Maziarz Richard T; Molina Arturo; Pavlovsky Santiago; Pecora Andrew L; Schouten Harry C; Shea Thomas C; Lazarus Hillard M; Rizzo J Douglas; Vose Julie M
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.
Blood 2003;102(10):3521-9.
2003: Bierman Philip J; Sweetenham John W; Loberiza Fausto R; Taghipour Goli; Lazarus Hillard M; Rizzo J Douglas; Schmitz Norbert; van Besien Koen; Vose Julie M; Horowitz Mary; Goldstone Anthony;
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3744-53.
2003: Van Besien K; Devine S; Wickrema A; Jessop E; Amin K; Yassine M; Maynard V; Stock W; Peace D; Ravandi F; Chen Y-H; Hoffman R; Sossman J
Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.
Bone marrow transplantation 2003;32(5):471-6.
2003: Baron Beverly W; van Besien Koen; Hoffman Philip C; Kohn Orly F; Rossof Arthur H; Baron Joseph M
Thrombotic thrombocytopenic purpura after cephalosporin administration: a possible relationship.
Transfusion 2003;43(9):1317-21.
2003: van Besien K; Devine S; Wickrema A; Jessop E; Amin K; Yassine M; Maynard V; Stock W; Peace D; Ravandi F; Chen Y-H; Cheung T; Vijayakumar S; Hoffman R; Sosman J
Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
Bone marrow transplantation 2003;32(1):9-13.
2003: Verma A; Devine S; Morrow M; Chen Y-H; Mihalov M; Peace D; Stock W; Pursell K; Wickrema A; Yassine M; Jessop E; van Besien K
Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir.
Bone marrow transplantation 2003;31(9):813-6.
2003: Levine John E; Harris Richard E; Loberiza Fausto R; Armitage James O; Vose Julie M; Van Besien Koen; Lazarus Hillard M; Horowitz Mary M; Bashey Asad; Bolwell Brian J; Burns Linda J; Cairo Mitchell S; Champlin Richard E; Freytes Cesar O; Gibson John; Goldstein Steve C; Laughlin Mary J; Lister John; Marks David I; Maziarz Richard T; Miller Alan M; Milone Gustavo A; Pavlovsky Santiago; Pecora Amdrew L; Rizzo J Douglas; Schiller Gary; Schouten Harry C; Zhang Mei Jie;
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.
Blood 2003;101(7):2476-82.
2003: de Lima Marcos; Ravandi Farhad; Shahjahan Munir; Andersson Borje; Couriel Daniel; Donato Michele; Khouri Issa; Gajewski James; van Besien Koen; Champlin Richard; Giralt Sergio; Kantarjian Hagop
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.
Cancer 2003;97(5):1242-7.
2002: G-Amlak Maaza; Uddin Shahab; Mahmud Dolores; Damacela Ingrid; Lavelle Donald; Ahmed Maqbool; van Besien Koen; Wickrema Amittha
Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway.
Biochemical and biophysical research communications 2002;297(4):760-4.
2002: Verma Amit; Deb Dilip K; Sassano Antonella; Kambhampati Suman; Wickrema Amittha; Uddin Shahab; Mohindru Mani; Van Besien Koen; Platanias Leonidas C
Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(12):5984-8.
2002: Devine Steven M; Jahagirdar Balkrishna; van Besien Koen
Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma.
Blood 2002;99(11):4251-2; author reply 4252.
2002: Devine Steven M; Hoffman Ron; Verma Amit; Shah Rajul; Bradlow Basil A; Stock Wendy; Maynard Vera; Jessop Ellen; Peace David; Huml Marianne; Thomason Deana; Chen Yi-Hsiang; van Besien Koen
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia.
Blood 2002;99(6):2255-8.
2001: Devine S M; Sanborn R; Jessop E; Stock W; Huml M; Peace D; Wickrema A; Yassine M; Amin K; Thomason D; Chen Y H; Devine H; Maningo M; van Besien K
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
Bone marrow transplantation 2001;28(6):557-62.
2001: van Besien K; Koshy M; Anderson-Shaw L; Talishy N; Dorn L; Devine S; Yassine M; Kodish E
Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions.
Bone marrow transplantation 2001;28(6):545-9.
2001: Przepiorka D; Anderlini P; Saliba R; Cleary K; Mehra R; Khouri I; Huh Y O; Giralt S; Braunschweig I; van Besien K; Champlin R
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation.
Blood 2001;98(6):1695-700.
2001: van Besien K; Keralavarma B; Devine S; Stock W
Allogeneic and autologous transplantation for chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(9):1317-25.
2001: Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno N T; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson B S; Estey E H; Champlin R; Przepiorka D
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
American journal of hematology 2001;67(4):227-33.
2001: van Besien K; Kelta M; Bahaguna P
Primary mediastinal B-cell lymphoma: a review of pathology and management.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1855-64.
2001: Lazarus H M; Loberiza F R; Zhang M J; Armitage J O; Ballen K K; Bashey A; Bolwell B J; Burns L J; Freytes C O; Gale R P; Gibson J; Herzig R H; LeMaistre C F; Marks D; Mason J; Miller A M; Milone G A; Pavlovsky S; Reece D E; Rizzo J D; van Besien K; Vose J M; Horowitz M M
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Bone marrow transplantation 2001;27(4):387-96.
2001: Sosman J A; Stiff P; Moss S M; Sorokin P; Martone B; Bayer R; van Besien K; Devine S; Stock W; Peace D; Chen Y; Long C; Gustin D; Viana M; Hoffman R
Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):634-44.
2001: Vose J M; Zhang M J; Rowlings P A; Lazarus H M; Bolwell B J; Freytes C O; Pavlovsky S; Keating A; Yanes B; van Besien K; Armitage J O; Horowitz M M;
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):406-13.
2000: van Besien K; Bartholomew A; Stock W; Peace D; Devine S; Sher D; Sosman J; Chen Y H; Koshy M; Hoffman R
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.
Bone marrow transplantation 2000;26(4):445-9.
2000: de Lima M; van Besien K; Gajewski J; Khouri I; Andersson B; Korbling M; Champlin R; Giralt S
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
Bone marrow transplantation 2000;26(3):333-8.
2000: Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri I F; Folloder J; Ueno N T; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson B S; Champlin R
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(2A):190-7.
1999: Donato M L; Champlin R E; Van Besien K W; Korbling M; Cabanillas F; Anderlini P; Gajewski J G; Lauppe J; Durett A; Andersson B; Giralt S; Khouri I; Hagemeister F; Romaguera J E; Sarris A; McLaughlin P; Younes A; Ippoliti C; Blamble D A; Hester J; Gee A; Rodriguez M A
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;35(3-4):317-24.
1999: Przepiorka D; Khouri I; Ippoliti C; Ueno N T; Mehra R; Körbling M; Giralt S; Gajewski J; Fischer H; Donato M; Cleary K; Claxton D; Chan K W; Braunschweig I; van Besien K; Andersson B S; Anderlini P; Champlin R
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.
Bone marrow transplantation 1999;24(7):763-8.
1999: Przepiorka D; Smith T L; Folloder J; Khouri I; Ueno N T; Mehra R; Körbling M; Huh Y O; Giralt S; Gajewski J; Donato M; Cleary K; Claxton D; Braunschweig I; van Besien K; Andersson B S; Anderlini P; Champlin R
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.
Blood 1999;94(4):1465-70.
1999: Warkentin D; Ippoliti C; Bruton J; Van Besien K; Champlin R
Toxicity of single daily dose gentamicin in stem cell transplantation.
Bone marrow transplantation 1999;24(1):57-61.
1999: Przepiorka D; van Besien K; Khouri I; Hagemeister F; Samuels B; Folloder J; Ueno N T; Molldrem J; Mehra R; Körbling M; Giralt S; Gajewski J; Donato M; Cleary K; Claxton D; Braunschweig I; Andersson B; Anderlini P; Champlin R
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):527-32.
1999: Przepiorka D; Khouri I; Thall P; Mehra R; Lee M S; Ippoliti C; Giralt S; Gajewski J; van Besien K; Andersson B; Körbling M; Deisseroth A B; Champlin R
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
Bone marrow transplantation 1999;23(10):977-81.
1999: Lazarus H M; Rowlings P A; Zhang M J; Vose J M; Armitage J O; Bierman P J; Gajewski J L; Gale R P; Keating A; Klein J P; Miller C B; Phillips G L; Reece D E; Sobocinski K A; van Besien K; Horowitz M M
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):534-45.
1998: van Besien K; Sobocinski K A; Rowlings P A; Murphy S C; Armitage J O; Bishop M R; Chaekal O K; Gale R P; Klein J P; Lazarus H M; McCarthy P L; Raemaekers J M; Reiffers J; Phillips G L; Schattenberg A V; Verdonck L F; Vose J M; Horowitz M M
Allogeneic bone marrow transplantation for low-grade lymphoma.
Blood 1998;92(5):1832-6.
1998: Ueno N T; Rondón G; Mirza N Q; Geisler D K; Anderlini P; Giralt S A; Andersson B S; Claxton D F; Gajewski J L; Khouri I F; Körbling M; Mehra R C; Przepiorka D; Rahman Z; Samuels B I; van Besien K; Hortobagyi G N; Champlin R E
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):986-93.
1998: van Besien K; Ha C S; Murphy S; McLaughlin P; Rodriguez A; Amin K; Forman A; Romaguera J; Hagemeister F; Younes A; Bachier C; Sarris A; Sobocinski K S; Cox J D; Cabanillas F
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
Blood 1998;91(4):1178-84.
1998: Popat U; Przepiork D; Champlin R; Pugh W; Amin K; Mehra R; Rodriguez J; Giralt S; Romaguera J; Rodriguez A; Preti A; Andersson B; Khouri I; Claxton D; de Lima M; Donato M; Anderlini P; Gajewski J; Cabanillas F; van Besien K
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):63-9.
1997: Ippoliti C; Morgan A; Warkentin D; van Besien K; Mehra R; Khouri I; Giralt S; Gajewski J; Champlin R; Andersson B; Przepiorka D
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
Bone marrow transplantation 1997;20(6):491-5.
1997: van Besien K; Thall P; Korbling M; Pugh W C; Khouri I; Mehra R; Giralt S; Anderlini P; Amin K; Mirza N; Seong D; Gajewski J; Hester J; Andersson B; Cabanillas F; Champlin R; Przepiorka D
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(3):150-6.
1997: Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan K W; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):76-82.
1997: van Besien K; Forman A; Champlin R
Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(6):515-24.
1997: Giralt S; Estey E; Albitar M; van Besien K; Rondón G; Anderlini P; O'Brien S; Khouri I; Gajewski J; Mehra R; Claxton D; Andersson B; Beran M; Przepiorka D; Koller C; Kornblau S; Kørbling M; Keating M; Kantarjian H; Champlin R
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Blood 1997;89(12):4531-6.
1997: Rondón G; Giralt S; Pereira M; Van Besien K; Mehra R; Champlin R; Andreeff M
Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization.
Leukemia & lymphoma 1997;25(5-6):463-7.
1997: van Besien K W; de Lima M; Giralt S A; Moore D F; Khouri I F; Rondón G; Mehra R; Andersson B S; Dyer C; Cleary K; Przepiorka D; Gajewski J L; Champlin R E
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
Bone marrow transplantation 1997;19(10):977-82.
1997: Khouri I F; Przepiorka D; van Besien K; O'Brien S; Palmer J L; Lerner S; Mehra R C; Vriesendorp H M; Andersson B S; Giralt S; Körbling M; Keating M J; Champlin R E
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease.
British journal of haematology 1997;97(2):466-73.
1997: van Besien K; Verschraegen C; Mehra R; Giralt S; Kudelka A P; Edwards C L; Piamsonboom S; Termrungruanglert W; Champlin R; Kavanagh J J
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue.
Gynecologic oncology 1997;65(2):366-9.
1997: Giralt S; Davis M; O'Brien S; van Besien K; Champlin R; de Vos D; Kantarjian H
Studies of decitabine with allogeneic progenitor cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 1():S32-4.
1997: Przepiorka D; Anderlini P; Ippoliti C; Khouri I; Fietz T; Thall P; Mehra R; Giralt S; Gajewski J; Deisseroth A B; Cleary K; Champlin R; van Besien K; Andersson B; Körbling M
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
Bone marrow transplantation 1997;19(5):455-60.
1997: Giralt S; Weber D; Colome M; Dimopoulos M; Mehra R; Van Besien K; Gajewski J; Andersson B; Khouri I; Przepiorka D; von Wolff B; Delasalle K; Korbling M; Seong D; Alexanian R; Champlin R
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):667-73.
1997: de Lima M; van Besien K W; Giralt S A; Khouri I F; Mehra R; Andersson B S; Przepiorka D; Gajewski J L; Korbling M; Champlin R E
Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
Bone marrow transplantation 1997;19(2):121-7.
1997: Piamsomboon S; Kudelka A P; Termrungruanglert W; Van Besien K; Edwards C L; Lifshitz S; Schomer D F; Champlin R; Mante R P; Kavanagh J J; Verschraegen C F
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature.
European journal of gynaecological oncology 1997;18(6):453-6.
1997: Verschraegen C F; van Besien K W; Dignani C; Hester J P; Andersson B S; Anaissie E
Invasive Aspergillus sinusitis during bone marrow transplantation.
Scandinavian journal of infectious diseases 1997;29(4):436-8.
1996: Przepiorka D; Ippoliti C; Khouri I; Anderlini P; Mehra R; Giralt S; Gajewski J; Fritsche H; Deisseroth A B; Cleary K; Champlin R; van Besien K; Andersson B; Korbling M
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
Transplantation 1996;62(12):1806-10.
1996: Körbling M; Chan K W; Anderlini P; Seong D; Durett A; Langlinais A; Przepiorka D; Gajewski J; Miller P; Sundberg J; Alilaen P; Bojko P; Mirza N; Claxton D; van Besien K; Khouri I; Andersson B; Mehra R; Champlin R
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
Bone marrow transplantation 1996;18(5):885-90.
1996: van Besien K; Przepiorka D; Mehra R; Giralt S; Khouri I; Gajewski J; Andersson B; Champlin R
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):3036-42.
1996: van Besien K W; Mehra R C; Giralt S A; Kantarjian H M; Pugh W C; Khouri I F; Moon Y; Williams P; Andersson B S; Przepiorka D; McCarthy P L; Gajewski J L; Deisseroth A B; Cabanillas F F; Champlin R
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
The American journal of medicine 1996;100(3):299-307.
1996: Giralt S A; van Besien K
Treatment of relapse after allogeneic bone marrow transplantation.
Cancer treatment and research 1996;84():279-90.
1996: van Besien K; Giralt S
Autologous bone marrow transplantation for leukemia and lymphoma.
Cancer treatment and research 1996;84():207-59.
1995: Ippoliti C; Przepiorka D; Mehra R; Neumann J; Wood J; Claxton D; Gajewski J; Khouri I; van Besien K; Andersson B
Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation.
Urology 1995;46(6):811-5.
1995: Giralt S; Hester J; Huh Y; Hirsch-Ginsberg C; Rondón G; Seong D; Lee M; Gajewski J; Van Besien K; Khouri I; Mehra R; Przepiorka D; Körbling M; Talpaz M; Kantarjian H; Fischer H; Deisseroth A; Champlin R
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Blood 1995;86(11):4337-43.
1995: Körbling M; Huh Y O; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth A B; Champlin R E
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Blood 1995;86(7):2842-8.
1995: Giralt S; O'Brien S; Talpaz M; Van Besien K; Chan K W; Rondón G; Andersson B; Mehra R; Khouri I; Estey E
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation.
Cytokines and molecular therapy 1995;1(2):115-22.
1995: van Besien K W; Khouri I F; Giralt S A; McCarthy P; Mehra R; Andersson B S; Przepiorka D; Gajewski J L; Bellare N; Nath R
Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1096-102.
1995: van Besien K; Tabocoff J; Rodriguez M; Andersson B; Mehra R; Przepiorka D; Dimopoulos M; Giralt S; Suki S; Khouri I
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.
Bone marrow transplantation 1995;15(4):549-55.
1995: Körbling M; Przepiorka D; Huh Y O; Engel H; van Besien K; Giralt S; Andersson B; Kleine H D; Seong D; Deisseroth A B
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.
Blood 1995;85(6):1659-65.
1995: van Besien K; Demuynck H; Lemaistre C F; Bogaerts M A; Champlin R
High-dose melphalan allows durable engraftment of allogeneic bone marrow.
Bone marrow transplantation 1995;15(2):321-3.
1994: Giralt S A; LeMaistre C F; Vriesendorp H M; Andersson B S; Dimopoulos M; Gajewski J; Van Besien K; Mehra R; Przepiorka D; Khouri I
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(9):1923-30.
1994: Khouri I F; Keating M J; Vriesendorp H M; Reading C L; Przepiorka D; Huh Y O; Andersson B S; van Besien K W; Mehra R C; Giralt S A
Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):748-58.
1994: Przepiorka D; Ippoliti C; Panina A; Goodrich J; Giralt S; van Besien K; Mehra R; Deisseroth A B; Andersson B; Luna M
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.
Bone marrow transplantation 1994;13(4):461-4.
1993: Dimopoulos M A; Alexanian R; Przepiorka D; Hester J; Andersson B; Giralt S; Mehra R; van Besien K; Delasalle K B; Reading C
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma.
Blood 1993;82(8):2324-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Koen van Besien

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Phenomena

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Koen van Besien (preview)

All Publications